Member States need to put this policy into national law by 30 April 2006.

Directive 2004/36 Directive) is designed controls checks third-country aircraft that EU airports and to collect and centralize information of the results of such inspections. As a result, information is available to all Member States on any infringements of international air safety rules. Member States need to put this policy into national law by 30 April 2006. A European agency for ensuring the security levels.

Talor an update on the work that with the development with the development of dendritic vaccines for other emerging viral diseases.. CEL-SCI Corporation announced today that Eyal Talor, Chief Scientific Officer, will give a presentation titled ‘LEAPS Peptides and Protein Vaccines and Multikin immunotherapy of cancer ’14 April at the World Vaccine Congress 2011. Around 02.50 clock at the Gaylord National Hotel and Convention Center, Washington DC The conference brings together North America’s leading governmental, business and academic head as they continue to improve scientific and strategic innovation behind the emerging vaccine industry.‘. The FDA has removed Caesium-131 for use in the treatment of cancer in the body including chest and brain tumors.

Source: ISORAY.. ISORAY Chief Executive Dwight Babcock says the latest advances reflects the strategic plan, initial focus on leading medical institutions to world to expanded use society patented Cs-131 brachytherapy work the entire body further. ‘From our initial focus on the treatment of prostatic cancer, we see increasing revenues of new equality bodies addressing of cancer diseases throughout the body.

Use of Cs-131 brachytherapy Metastatic cancer is the newest development the growing adoption of these seminal the internal radiotherapy for cancer diseases throughout the body.